APOBEC3B and breast carcinoma: Then, we genotyped approximately 12,500 unselected cases of breast cancer and 3700 cancer-free controls for the c.783delG founder mutation and compared the clinical characteristics of breast tumors in carriers of the APOBEC3B mutation with cancers diagnosed among non-carriers.